Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Guardant Health Inc
(NQ:
GH
)
28.54
-0.51 (-1.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,247,860
Open
29.67
Bid (Size)
28.50 (1)
Ask (Size)
28.80 (1)
Prev. Close
29.05
Today's Range
28.33 - 30.02
52wk Range
15.81 - 41.06
Shares Outstanding
101,298,669
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
August 12, 2024
The widely followed growth investor was a buyer at the end of a very volatile trading week.
Via
The Motley Fool
Cathie Wood's Ark Invest Continues Loads Up On $6.05M Worth Of Robinhood Shares Amid Bitcoin Rebound, Dumps Zoom Stock
August 08, 2024
On Thursday, Cathie Wood-led Ark Invest made some significant trades, notably buying Robinhood Markets Inc (NASDAQ:HOOD) and selling Zoom Video Communications Inc (NASDAQ:ZM).
Via
Benzinga
Performance
YTD
+7.66%
+7.66%
1 Month
-9.51%
-9.51%
3 Month
+10.83%
+10.83%
6 Month
+29.43%
+29.43%
1 Year
-19.36%
-19.36%
More News
Read More
Guardant Health to Participate in Upcoming Investor Conferences
August 08, 2024
From
Guardant Health, Inc.
Via
Business Wire
Key Takeaways From Guardant Health Analyst Ratings
August 08, 2024
Via
Benzinga
GH Stock Earnings: Guardant Health Beats EPS, Beats Revenue for Q2 2024
August 07, 2024
Via
InvestorPlace
Assessing Guardant Health: Insights From 7 Financial Analysts
July 17, 2024
Via
Benzinga
Where Guardant Health Stands With Analysts
June 28, 2024
Via
Benzinga
Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
August 07, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Colorectal Cancer
August 07, 2024
From
Guardant Health, Inc.
Via
Business Wire
Why Exact Sciences, Up 20%, Is 'Coiled To Snap Back' After Quarterly Beat
August 01, 2024
Via
Investor's Business Daily
Guardant Health’s FDA-approved Shield™ Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer
August 01, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence Strategies
August 01, 2024
From
Guardant Health, Inc.
Via
Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
July 31, 2024
Via
The Motley Fool
FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption
July 29, 2024
Via
Benzinga
Exposures
Product Safety
Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
July 29, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024
July 24, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360® Test, Further Extending Its Best-in-Class Performance
July 23, 2024
From
Guardant Health, Inc.
Via
Business Wire
Goldman Sachs Says Buy These 3 Stocks for Double-Digit Returns
July 22, 2024
Via
InvestorPlace
3 Precision Medicine Stocks Tailoring Treatments
July 21, 2024
Via
InvestorPlace
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
July 18, 2024
Via
Benzinga
Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors
July 18, 2024
From
Guardant Health, Inc.
Via
Business Wire
3 Biotech Moonshots With Imminent Catalyst Potential
July 03, 2024
Via
InvestorPlace
The 3 Best Personalized Medicine Stocks to Buy in July 2024
July 03, 2024
Via
InvestorPlace
From ‘Sell’ to ‘Strong Buy’: 3 Dramatic Analyst U-Turns to Watch
July 02, 2024
Via
InvestorPlace
Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer
June 04, 2024
From
Guardant Health, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.